ETF:ONEQ | ETF Holdings Page 11 | Fidelity Nasdaq Composite Index ETF

ONEQ ETF holdings Page 11

Weights reproduce the dated portfolio and may not sum to exactly 100% because of cash, derivatives, rounding, liabilities, or other positions. Provenance stays internal.

Snapshot fieldReported value
FundFidelity Nasdaq Composite Index ETF
Report date2026-02-28
Reported holdings1,024
SEC series IDS000006011

Positions 1,001–1,024 of 1,024

TickerIssuerWeightValue (USD)Balance
P3 HEALTH PARTNERS INCP3 HEALTH PARTNERS INC0.000072%6,494.583,078 NS
OPENDOOR TECHNOLOGIES INCOPENDOOR TECHNOLOGIES INC0.000058%5,205.796,190 NS
OPENDOOR TECHNOLOGIES INCOPENDOOR TECHNOLOGIES INC0.00003%2,686.466,190 NS
OPENDOOR TECHNOLOGIES INCOPENDOOR TECHNOLOGIES INC0.000025%2,290.36,190 NS
OMNIAB INC/OLDOMNIAB INC/OLD0.000012%1,090.42,320 NS
OMNIAB INC/OLDOMNIAB INC/OLD0.000009%835.22,320 NS
LIGAND PHARMACEUTICALS INCLIGAND PHARMACEUTICALS INC0.000001%114.751,530 NS
LIGAND PHARMACEUTICALS INCLIGAND PHARMACEUTICALS INC0.000001%82.541,530 NS
CARISMA THERAPEUTICS INCCARISMA THERAPEUTICS INC0%4.49449,253 NS
LIGAND PHARMACEUTICALS INCLIGAND PHARMACEUTICALS INC0%3.061,530 NS
SATSUMA PHARMACEUTICALS INCSATSUMA PHARMACEUTICALS INC0%2.18218,164 NS
LIGAND PHARMACEUTICALS INCLIGAND PHARMACEUTICALS INC0%2.141,530 NS
KINNATE BIOPHARMA INCKINNATE BIOPHARMA INC0%0.5150,749 NS
OZON HOLDINGS PLCOZON HOLDINGS PLC0%0.2222,100 NS
AZNASTRAZENECA PLC0%0.2221,510 NS
CLEMENTIA PHARMACEUTICALS INCCLEMENTIA PHARMACEUTICALS INC0%0.220,215 NS
APPLIED GENETIC TECHNOLOGIES CORPAPPLIED GENETIC TECHNOLOGIES CORP0%0.1414,225 NS
CINCOR PHARMA INCCINCOR PHARMA INC0%0.1212,042 NS
DOVA PHARMACEUTICALS INCDOVA PHARMACEUTICALS INC0%0.087,729 NS
TOBIRA THERAPEUTICS INCTOBIRA THERAPEUTICS INC0%0.021,750 NS
MIRATI THERAPEUTICS INCMIRATI THERAPEUTICS INC0%0.011,147 NS
2595777DROCHE HOLDING AG0%0.01870 NS
2450251DSANOFI0%0.01925 NS
NQH6CHICAGO MERCANTILE EXCH INC-0.003487%-314,319.1480 NC

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.